ArticleMedical devices (Auckland, N.Z.)2026
A Physiology-Based Bridging Framework for Preliminary Cross-Population Evaluation of Plateletpheresis Devices: A Case Study of the NGL XF3000.
Article in Medical devices (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Evaluation of new plateletpheresis devices across diverse donor populations traditionally relies on extensive multicenter clinical studies. This study proposes a physiology-based evaluation framework that integrates physiological modeling with external clinical observations to provide preliminary evidence for cross-population applicability. Methods: Physiological operating envelopes were derived from published anthropometric and hematological data together with established transfusion medicine principles. The framework was externally validated using published observations from the mature MCS+ plateletpheresis platform. The preliminary framework was subsequently applied to the NGL XF3000 by comparing its operating specifications and available clinical observations with the validated operating envelopes. Results: The predicted operating envelopes accommodated physiological variation across major ethnic populations and were consistent with the operating characteristics of both the MCS+ platform and the NGL XF3000. Published MCS+ observations supported the physiological assumptions underlying the framework, while the available NGL XF3000 data were comparable with published reference observations regarding blood component changes and remained within the validated performance envelope. Conclusion: The proposed framework provides a physiology-based, resource-efficient approach for the preliminary evaluation of plateletpheresis devices before large-scale clinical validation. By integrating mechanistic modeling with external clinical evidence, it may facilitate the regulatory assessment of new devices intended for use across diverse donor populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.